News & Updates
Filter by Specialty:

SGLT-2 inhibitors help avert death in patients with HFrEF
19 Nov 2024
byStephen Padilla
Use of SGLT-2 inhibitors may reduce the risk of all-cause and cardiovascular (CV) mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), reports a study.
SGLT-2 inhibitors help avert death in patients with HFrEF
19 Nov 2024
Fruit, vegetable diet a viable treatment for hypertension
19 Nov 2024
byStephen Padilla
A diet that is rich in fruits and vegetables can help treat individuals with primary hypertension by preventing chronic kidney disease (CKD) progression and reducing the risk of cardiovascular disease (CVD), suggest the results of a recent study.
Fruit, vegetable diet a viable treatment for hypertension
19 Nov 2024
Trastuzumab deruxtecan improves PFS in metastatic breast cancer, but ups ILD risk
18 Nov 2024
Treatment with trastuzumab deruxtecan (T-DXd) demonstrates efficacy in patients with metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) breast cancer but may result in adverse events, such as interstitial lung disease (ILD), suggests a study.